A podcast for physicians about evidence based medicine in rheumatology. Each week we'll critique and apply a paper in the medical literature.
E103: Len Calabrese on Monoclonal Antibodies for COVID-19
This week I took a twitter disagreement from the impersonal world of twitter to the podcast world of a back and forth conversation. Really enjoyed talking to Dr. Len Calabrese about monoclonal antibodies, FDA regulatory pathways, and life in general.
E102: Unintentional Unblinding in Rheumatic Disease Trials
Excited to share an editorial that I wrote along with Cody Bruggemeyer and Desh Nepal, two trainees with me at the Medical College of Wisconsin. We discussed what I believe to be a pervasive (but seldom discussed) issue in rheumatology RCTs: unblinding. I suspect many of our studies suffer from this. Have a listen!
E101: Pred v Colchicine for CPPD: COLCHICORT
Happy to share the FIRST randomized trial in CPPD today. It's kind of a weird study but worth a quick discussion.
E100: ADVOCATE Health Related Quality of Life
This week I dive into the health related quality of life measures that were reported in the ADVOCATE study. I found them overall somewhat convincing and they have affected my practice. Have a listen and be sure to follow along. Find my work at ebrheum.com
E99: Hospital Problems
Quick episode this week from a recent Perspective piece I had published in the New England Journal. Have a listen or a read!
E98: Key Opinion Leaders & ILD Guidelines
Podcast this week discussing key opinion leaders (KOLs) and pharmaceutical companies. Please subscribe to my newsletter (ebrheum.com) and be sure to share the podcast with friends!
Great reviews and understanding
I really appreciate how he helps explain why studies are good or bad and the deeper analysis techniques. Please keep these coming!
Requirement for Rheum Fellows
Thanks for all the hard work
Entertaining way to catch up on “hot topics” 👍🏻